期刊文献+

乙型肝炎病毒458nt-1308nt剪接特异性蛋白抗α-干扰素作用 被引量:2

The anti-IFN-a effects of the novel protein encoded by the 458 nt-1308 nt spliced variant of hepatitis B virus genome
原文传递
导出
摘要 目的研究乙型肝炎病毒(HBV)458nt-1308nt剪接特异性蛋白TSR′r′(源于HBVDNA聚合酶读码框,T代表TP区,S为Spacer区,R′为截短的RT区,r′为截短的RNaseH区)抗α-干扰素(IFN-α)作用并分析其功能区域。方法PCR扩增获得HBV458nt-1308t剪接变异体剪接特异性基因TSR′r′及其缺失突变体,并克隆于pcDNA3.1/HisC。重组载体以FuGENE6转染Huh7肝细胞,通过融合表达的多肽表位抗体,Western blot检测目的蛋白表达。TSR′r′及其缺失突变体重组载体分别与IFN-α反应报告载体p6-16CAT共转染Huh7肝细胞,转染后48h给予终浓度为100IU/ml的IFN-α2a刺激,作用24h后裂解细胞,检测胞内氯霉素乙酰基转移酶(CAT)含量。所有实验数据采用单因素方差分析法进行统计分析。结果构建TSR′r′及其缺失突变体重组真核表达载体,Western blot显示各基因片段在Huh7细胞中均表达相应蛋白。06-16CAT共转染结果显示,随着TSR′r′重组表达载体转染量的递增,Huh7胞内CAT值逐渐降低。此外,转染TP+Spacer区的缺失突变体可导致Huh7胞内CAT值显著下降,而其他各类TSR′r′缺失突变体共转染后胞内CAT值无变化。结论HBV458nt-1308nt剪接特异性蛋白抑制Huh7细胞对IFN-α的反应性,其活性与N端的TP及Spacer区有关。 Objective To investigate the anti-IFN-α effects of the novel protein TSR′r′ encoded by the 458 nt-1308 nt spliced variant of hepatitis B virus genome, and to determine its functional domains. Methods the TSR′r′ gene (originated from open reading frame of HBV DNA polymerase, T represents terminal protein region, S represents the Spacer region, R' represents the truncated reverse transcriptase region, and r′ represents the truncated RNaseH region) of the 458 nt-1308 nt spliced variant of HBV genome and its deletants were amplified by PCR and were cloned into the pcDNA3.1/HisC vector. The recombinant vector was transfected into Huh7 hepatocytes individually by FuGENE6 transfection reagent, and the expression of the fusion protein was detected by Western blot. Huh7 hepatocytes were co-transfected with p6-16CAT and the recombinant vector harboring either TSR′r′ or the related deletant, and treated with IFN-α 2a 48 h post transfection. After 24 h stimulating, the ceils were lysed and the intracellular CAT value was calculated. All data were processed with One-way analysis of variance(ANOVA). Results Recombinant vectors harboring either the TSR′r′ gene or related deletant were constructed successfully, and the fusion proteins were expressed well in Huh7 cells. When Huh7 hepatocytes were co-transfected with p6-16CAT and TSR′r′ recombinant, the intracellular CAT values reduced gradually as paralleled with the increasing amount of TSR′r′ recombinant. Furthermore, as compared with the empty vector, intracellular CAT values also decreased significantly when the Huh7 cells co-transfected with recombinant harboring TP plus Spacer regions, while any of the other deletants ( harboring either TP or Spacer region or neither) showed no significant difference. Conclusion The novel protein encoded by the 458 nt-1308 nt spliced variant of hepatitis B virus genome suppressed the response of Huh7 hepatocytes to IFN-α, and the N-terminal TP plus Spacer region was the functional domain of the protein for anti-IFN-α effects.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2008年第4期314-319,共6页 Chinese Journal of Microbiology and Immunology
基金 基金项目:全国优秀博士学位论文作者专项资金资助项目(200359) 福建省重大科技基金(2002F005) 福建省高等学校科技创新团队培育计划基金(FMU-RT001)
关键词 乙型肝炎病毒 RNA剪接 Α-干扰素 DNA聚合酶 Hepatitis B virus RNA splicing Interferon-α DNA polymerase
  • 相关文献

参考文献15

  • 1Wu HL, Chen PJ, Tu SJ, et al. Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells. J Virol, 1991, 65(4) : 1680-1686.
  • 2Soussan P, Garreau F, Zylberberg H, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest, 2000, 105(1) : 55-60.
  • 3Rosmorduc O, Petit MA, Pol S, et al. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology, 1995, 22(1) : 10-19.
  • 4陈婉南,黄清玲,林建银,王林,郭丹华,林旭.双剪接型2.2 kb乙型肝炎病毒基因组剪接变异体编码蛋白的反式激活作用[J].中华微生物学和免疫学杂志,2006,26(11):985-989. 被引量:4
  • 5Foster GR, Ackrill AM, Goldin RD, et al. Expression of the term inal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natt Acad Sci USA, 1991, 88(7) : 2888-2892.
  • 6王林,柏世玉,陈婉南,李晖,林建银,林旭.乙型肝炎病毒DNA聚合酶末端蛋白抗α-干扰素功能区域分析[J].中华微生物学和免疫学杂志,2007,27(6):540-545. 被引量:5
  • 7林旭,徐晓,郑大利,林万松,林建银.一种新型的乙型肝炎病毒剪接变异体[J].中华微生物学和免疫学杂志,2003,23(11):844-848. 被引量:3
  • 8Craxi A, Di Bona D, Camma C. Interferon alpha for HBeAg posi- tive chronic hepatitis B. J Hepatol, 2003, 39 (Suppl 1 ): 99- 105.
  • 9Brooke MG, McDonald JA, Karayiannis P, et al. Randomised controlled trial of interferon α 2a (RoferonA) for the treatment of chronic hepatitis B virus infection: factors that influence response. Gut, 1989, 30(8) : 1116-1122.
  • 10Foster GR, Goldin RD, Hay A, et al. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy. Hepatology, 1993, 17 (5) : 757-762.

二级参考文献32

  • 1Wu HL,Chen PJ,Tu SJ,et al.Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells.J Virol,1991,65(4):1680-1686.
  • 2Romorduc O,Petit MA,Pol S,et al.In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA.Lancet,1995,22:10-19.
  • 3Soussan P,Garreau F,Zylberberg H,et al.In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA.J Clin Invest,2000,105(1):55-60.
  • 4Günt her S,Sommer G,Iwanska A,et al.Heterogeneity and common feather of defective hepatitis B virus genome derived from spliced pregenomic RNA.Virology,1997,238(2):363-371.
  • 5Rosmorduc O,Sirma H,Soussan P,et al.Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein.J Gen Virol,1999,80(Pt5):1253-1262.
  • 6Rossner MT.Review:Hepatitis B virus X-gene product:A promiscuous transcriptional activator.J Med Virol,1992,36(2):101-117.
  • 7Huang TJ,Lu CC,Tsai JC,et al.Novel antoregulatory function of hepatitis B virus M protein on surface gene expression.J Biol Chem,2005,280(30):27742-27754.
  • 8Kekule AS,Lauer U,Meyer M,et al.The pres2/s region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.Nature,1990,343:457-461.
  • 9Ono M,Morisawa K,Nie J,et al.Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1.Cancer Res,1998,58:1813-1816.
  • 10Kim HS,Ryu CJ,Hong HJ.Hepatitis B virus preS1 functions as a transcriptional activation domain.J Gen Virol,1997,78:1083-1086.

共引文献15

同被引文献29

  • 1王林,柏世玉,陈婉南,李晖,林建银,林旭.乙型肝炎病毒DNA聚合酶末端蛋白抗α-干扰素功能区域分析[J].中华微生物学和免疫学杂志,2007,27(6):540-545. 被引量:5
  • 2Craxi A,Di Bona D,Camma C,et al. Interferon alpha for HBeAg positive chronic hepatitis B: systematic review [J]. J Hepatol,2003,39(Suppl 1 ) :S99- S105
  • 3Brook MG, McDonald JA, Karayianis P, et al. Randomized controlled trial of interferon-α2a (RoferonA) for the treatment of chronic hepatitis B infection: Factors that influence response [ J ]. Gut, 1989,30(8) : 1116-1122
  • 4Foster GR, Goldin RD, Hay A, et al. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy [ J ]. Hepatology, 1993 , 17 ( 5 ) : 757-762
  • 5Foster GR,Ackrill AM, Goldin RD, et al. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA [ J]. Proc Natl Acad Sci USA, 1991,88(7) : 2888-2892
  • 6Soussan P, Garreau F, Zylberberg H, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA[J]. J Clin Invest,2000,105( 1 ) :55-60
  • 7Romorduc O, Petit MA, Pol S, et al. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA [ J ]. Lancet, 1995,22( 1 ) :10-19
  • 8Gunther S, Li BC, Miska S, et al. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients [ J ]. J Virol, 1995,69(9) :5437-5444
  • 9Nakayoshi T, Maeshiro T, Nakasone H,et al. Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands : a prospective study[ J ]. J Med Virol, 2003,70(3) : 350-354
  • 10King JK, Yeh SH, Lin MW, et al. Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study [ J ]. Hepatology, 2002,36(6) : 1416-1424

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部